Eli Lilly is trading 4.68% lower at ARS 32,620.00 as broad risk-off pressure from geopolitical and rate concerns weighs on markets and healthcare stocks.
- Riyadh attacks and escalation concerns drove oil and Treasury yields higher; healthcare was down 1.49%.
- Shares rose 4.02% on October 7 before reversing on October 8. No clear company-specific catalyst was identified, and current valuation coverage did not point to a new event explaining the decline.